BioSpace News Archive

Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today it had held a scheduled teleconference on April 28, 2020 with the US FDA as the next step for obtaining sales and marketing approval of its LuViva Advanced Cervical Scan. As a previous step, the Company filed on February 17, 2020 its FDA Pre-

Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) noted that investigators at the National Cancer Institute (NCI) and National Institute of Neurological Disorders and Stroke (NINDS) reported that Lixte’s lead clinical compound, LB-100, enhanced pharmacological immunotherapy of intracranial brain tumors in immune-competent mice including 25% complete regression and immunity to tumor rechallenge (Journal of Neuro-oncology, on-line April 27

Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, has completed its previously announced acquisition of Exalenz Bioscience Ltd., the Modiin, Israel based provider of the BreathID® Breath Test Systems, a urea breath test platform for the detection of Helicobacter pylori.

As Florida’s economy slowly prepares to re-open, Tampa General Hospital will continue using strict safety guidelines to begin performing elective surgeries and procedures next week

Notable, which is redefining cancer treatment with its scientific technology platform to rapidly advance drug development, announced a partnership today with the MDS Foundation.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its first quarter 2020 financial results and provide a corporate update on Thursday, May 7, 2020 , after the close of the U.S. financial markets. The Company will host a question and answer session via conference call and live webcast with the investment community the same day at

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, May 7, 2020 to report its first quarter 2020 financial results and provide a corporate update. To access the live conference call, please dial 866-595-4538 (domestic) or 636-812-6496 (international), and

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2020 following the close of regular trading on Tuesday, May 12, 2020. The earnings news release will be followed by a conference call at 3:00 p.m. Mountain Time that day. This call will be webcast live and can be accessed at the company’s website at investors.vareximaging.com

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced the appointment of biotech and finance industry veteran Ron Renaud as a director and non-executive chair of the board of directors. “We are honored to have Ron Renaud lead our board of directors

Rheonix Inc . Receives FDA Emergency Use Authorization for Rapid, Fully Automated Molecular COVID-19 Test